341 related articles for article (PubMed ID: 25848217)
21. Novel polydatin-loaded chitosan nanoparticles for safe and efficient type 2 diabetes therapy: In silico, in vitro and in vivo approaches.
Abdel-Moneim A; El-Shahawy A; Yousef AI; Abd El-Twab SM; Elden ZE; Taha M
Int J Biol Macromol; 2020 Jul; 154():1496-1504. PubMed ID: 31758992
[TBL] [Abstract][Full Text] [Related]
22. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
Al Asmari AK; Ullah Z; Tariq M; Fatani A
Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
[TBL] [Abstract][Full Text] [Related]
24. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
Zhang Z; Lv H; Zhou J
Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
[TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery.
Yuan Z; Gu X
Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633
[TBL] [Abstract][Full Text] [Related]
26. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy.
Gu Y; Ma J; Fu Z; Xu Y; Gao B; Yao J; Xu W; Chu K; Chen J
Int J Nanomedicine; 2019; 14():8805-8818. PubMed ID: 31806973
[TBL] [Abstract][Full Text] [Related]
27. [Preparation and Characterization of Clopidogrel Bisulfate Liposomes].
Wu BQ; He YJ; Yin ZN; Zhang ZR; Deng L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):630-636. PubMed ID: 34323042
[TBL] [Abstract][Full Text] [Related]
28. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
Jain S; Kumar D; Swarnakar NK; Thanki K
Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
[TBL] [Abstract][Full Text] [Related]
29. In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration.
Liu C; Shi J; Dai Q; Yin X; Zhang X; Zheng A
Drug Dev Ind Pharm; 2015 Feb; 41(2):272-8. PubMed ID: 24252110
[TBL] [Abstract][Full Text] [Related]
30. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
[TBL] [Abstract][Full Text] [Related]
31. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4.
Ma L; Liu YL; Ma ZZ; Dou HL; Xu JH; Wang JC; Zhang X; Zhang Q
J Ocul Pharmacol Ther; 2009 Jun; 25(3):195-200. PubMed ID: 19456253
[TBL] [Abstract][Full Text] [Related]
32. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation.
Mohsen AM; AbouSamra MM; ElShebiney SA
Drug Dev Ind Pharm; 2017 Aug; 43(8):1254-1264. PubMed ID: 28330377
[TBL] [Abstract][Full Text] [Related]
33. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles.
Zu Y; Zhang Y; Wang W; Zhao X; Han X; Wang K; Ge Y
Drug Deliv; 2016; 23(3):981-91. PubMed ID: 24918466
[TBL] [Abstract][Full Text] [Related]
34. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release.
Venugopalarao G; Lakshmipathy R; Sarada NC
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):149-57. PubMed ID: 26491316
[TBL] [Abstract][Full Text] [Related]
36. Nanoformulation and Evaluation of Oral Berberine-Loaded Liposomes.
Duong TT; Isomäki A; Paaver U; Laidmäe I; Tõnisoo A; Yen TTH; Kogermann K; Raal A; Heinämäki J; Pham TM
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946815
[TBL] [Abstract][Full Text] [Related]
37. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles.
Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R
Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282
[TBL] [Abstract][Full Text] [Related]
38. A comparison between conventional liposome and drug-cyclodextrin complex in liposome system.
Wang WX; Feng SS; Zheng CH
Int J Pharm; 2016 Nov; 513(1-2):387-392. PubMed ID: 27640244
[TBL] [Abstract][Full Text] [Related]
39. Vincristine-sulphate-loaded liposome-templated calcium phosphate nanoshell as potential tumor-targeting delivery system.
Thakkar HP; Baser AK; Parmar MP; Patel KH; Ramachandra Murthy R
J Liposome Res; 2012 Jun; 22(2):139-47. PubMed ID: 22149643
[TBL] [Abstract][Full Text] [Related]
40. Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system.
Jeon SO; Hwang HJ; Oh DH; Seo JE; Chun KH; Hong SM; Kim MJ; Kim WC; Park MS; Yoon CH; Min KH; Suh CW; Lee S
J Microencapsul; 2012; 29(3):234-41. PubMed ID: 22214321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
